The future of dengue vaccines (Q34980736)

5 August 2017

1 reference

title

The future of dengue vaccines (English)

1 reference

5 August 2017

0 references

1

Scott B Halstead

1 reference

5 August 2017

2

Jacqueline Deen

1 reference

PubMed ID

12401270

5 August 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

5 August 2017

1 reference

5 August 2017

360

1 reference

5 August 2017

9341

1 reference

5 August 2017

1243-1245

1 reference

Clinical proof of principle for ChimeriVax: recombinant live, attenuated vaccines against flavivirus infections

5 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911276-1

7 January 2021

Dengue and dengue haemorrhagic fever

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911276-1

7 January 2021

Pathogenesis of dengue: challenges to molecular biology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911276-1

7 January 2021

Haiti: absence of dengue hemorrhagic fever despite hyperendemic dengue virus transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911276-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911276-1

7 January 2021

Fluid replacement in dengue shock syndrome: a randomized, double-blind comparison of four intravenous-fluid regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911276-1

7 January 2021

Acute management of dengue shock syndrome: a randomized double-blind comparison of 4 intravenous fluid regimens in the first hour

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911276-1

7 January 2021

Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911276-1

7 January 2021

A prospective study of dengue infections in Bangkok

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911276-1

7 January 2021

Risk factors in dengue shock syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911276-1

7 January 2021

A prospective seroepidemiologic study on dengue in children four to nine years of age in Yogyakarta, Indonesia I. studies in 1995-1996.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911276-1

7 January 2021

Strong HLA class I--restricted T cell responses in dengue hemorrhagic fever: a double-edged sword?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911276-1

7 January 2021

Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911276-1

7 January 2021

Effect of dengue-1 antibodies on American dengue-2 viral infection and dengue haemorrhagic fever

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911276-1

7 January 2021

Antibodies that block virus attachment to Vero cells are a major component of the human neutralizing antibody response against dengue virus type 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911276-1

7 January 2021

Chimeric dengue type 2 (vaccine strain PDK-53)/dengue type 1 virus as a potential candidate dengue type 1 virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911276-1

7 January 2021

Development of new vaccines against dengue fever and Japanese encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911276-1

7 January 2021

Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3'-untranslated region.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911276-1

7 January 2021

Derivation and characterization of a dengue type 1 host range-restricted mutant virus that is attenuated and highly immunogenic in monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911276-1

7 January 2021

Live attenuated tetravalent dengue vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911276-1

7 January 2021

Accelerating the development and introduction of a dengue vaccine for poor children, 5-8 December 2001, Ho Chi Minh City, VietNam

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911276-1

7 January 2021

10.1016/S0140-6736(02)11276-1

Identifiers

DOI

1 reference

5 August 2017

1 reference

PubMed ID

12401270